Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMCQF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fmcqf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Fresenius Medical Care AG & Co. KGaA (FMCQF) measures how much investors pay for each dollar of the company's trailing earnings. FMCQF's current PE ratio of 11.09x is calculated by dividing its stock price of $45.17 by its TTM earnings per share of $3.43. −36.8% discount vs 5Y avg 17.6x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%18.5x
MedianQ3 · 75%25.3x
Max
At 11.09x, FMCQF's current P/E is lower than in 5% of its annual fiscal year readings over the past 20 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Fresenius Medical Care AG & Co. KGaAYou FMCQF | $12.1B | 11.09x | -65.2% | $3.43 |
 Astellas Pharma Inc. ALPMY | $24.3B | 14.92x | -53.1% | $172.58 |
 Bangkok Dusit Medical Services Public Company Limited BDULF | $8.9B | 19.24x | -39.6% | $1.00 |
 Bangkok Dusit Medical Services Public Company Limited BDUUY | $9.3B | 20.12x | -36.8% | $38.24 |
 bioMérieux S.A. BMXMF | $9.9B | 32.65x | +2.6% | $3.37 |
 Grifols, S.A. GIKLY | $15.0B | 18.68x | -41.3% | $0.28 |
 Sartorius AG SARTF | $15.0B | 85.39x | +168.2% | $2.24 |
Industry Average 6 peers with valid PE | — | 31.83x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 11.79x | $3.36 | -50.7% | |
2024-12-31 FY2024 | 23.90x | $1.83 | +8.3% | |
2023-12-31 FY2023 | 22.07x | $1.70 | +70.3% | |
2022-12-31 FY2022 | 12.96x | $2.30 | -23.8% | |
2021-12-31 FY2021 | 17.01x | $3.31 | +0.5% | |
2020-12-31 FY2020 | 16.93x | $3.96 | +2.4% | |
2019-12-31 FY2019 | 16.52x | $3.96 | +89.7% | |
2018-12-31 FY2018 | 8.71x | $6.47 | -58.7% | |
2017-12-31 FY2017 | 21.10x | $4.18 | +1.3% | |
2016-12-31 FY2016 | 20.82x | $3.87 | -17.9% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Fresenius Medical Care AG & Co. KGaA (FMCQF) measures how much investors pay for each dollar of the company's trailing earnings. FMCQF's current PE ratio of 11.09x is calculated by dividing its stock price of $45.17 by its TTM earnings per share of $3.43.
Frequently asked questions
FMCQF pe ratio · 6 questionsFMCQF's current PE ratio is 11.09x as of 2026-06-08, based on a stock price of $45.17 and TTM EPS of $3.43. Data sourced from Financial Modeling Prep via FMCQF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fresenius Medical Care AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08